Morbidity and Mortality Rate of Post-transplantation Lymphoproliferative Disorders after Epstein-Barr Virus Infection in Liver Transplant Recipients in Shiraz, Iran
Abstract
Background:
Epstein-Barr virus (EBV) primary infection and/or reactivation are suggested to play a significant role in the incidence of post-transplantation lymphoproliferative disorders (PTLD) and some other complications in immunocompromised patients, especially organ recipients. We assessed EBV viral load in EBV/PTLD suspected liver transplant recipients at specified times after transplantation and evaluated the respective clinical findings and post-transplant complications.
Materials and Methods:
Of 696 patients who underwent liver transplantation, the EBV viral load of 127 patients suspected of EBV infection/disease was examined intermittently in this retrospective study. Sampling was performed over a 4-year period from July 2013 to May 2017 using Taq-Man Real-Time Polymerase chain reaction (PCR) assay. Clinical and pathological data were gathered through the review of medical records.
Results:
The most common and leading cause of liver transplantation was HBV end-stage with 12% frequency; however, in 39% of patients, the underlying disease was unknown.
In total, 78 out of 127 (61%) suspected patients exhibited EBV-DNemia, and 19 of them were associated with PTLD. The median viral load in patients with PTLD was significantly higher than in non-affected patients (4035 copy/mL vs. 500 copy/mL, P<0.05). Among the PTLD cases, 13 were living, and six expired. Of the non-PTLD cases, 57 were living, and two expired.
Totally, PTLD was diagnosed clinically in 34 subjects (4.9%). The estimated mortality rate in patients with PTLD was 35% during 1.5 years post-transplantation follow-up.
Conclusion:
We concluded that monitoring of EBV load might detect EBV infection/disease in liver transplant suspected recipients even several weeks before the onset of any manifestation, especially in pediatric cases in whom PTLD incidence and its mortality are high.
Keywords
Full Text:
PDFCopyright (c) 2022 GOVARESH

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.